Eagle Asset Management Inc Kura Oncology, Inc. Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$10.71 - $14.6 $342,794 - $467,302	-32,007 Reduced 7.85%	375,493 $4.59 Million
Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $3.52 Million - $5.29 Million	-313,138 Reduced 43.45%	407,500 $5.06 Million
Q3 2022 Nov 07, 2022	SELL	$12.01 - $19.45 $260,484 - $421,851	-21,689 Reduced 2.92%	720,638 $9.84 Million
Q2 2022 Aug 10, 2022	SELL	$10.71 - $18.33 $305,899 - $523,541	-28,562 Reduced 3.71%	742,327 $13.6 Million
Q1 2022 May 12, 2022	BUY	$11.78 - $16.98 $394,276 - $568,320	33,470 Added 4.54%	770,889 $12.4 Million
Q4 2021 Feb 11, 2022	SELL	$12.22 - $19.57 $775,175 - $1.24 Million	-63,435 Reduced 7.92%	737,419 $10.5 Million
Q3 2021 Nov 10, 2021	SELL	$15.42 - $21.72 $5,535 - $7,797	-359 Reduced 0.04%	800,854 $15 Million
Q2 2021 Aug 11, 2021	SELL	$20.85 - $29.88 $916,920 - $1.31 Million	-43,977 Reduced 5.2%	801,213 $16.7 Million
Q1 2021 May 14, 2021	BUY	$24.75 - $39.14 $1.37 Million - $2.16 Million	55,226 Added 6.99%	845,190 $24.8 Million
Q4 2020 Feb 12, 2021	SELL	$29.0 - $41.62 $20.7 Million - $29.7 Million	-713,487 Reduced 47.46%	789,964 $25.8 Million
Q3 2020 Nov 12, 2020	SELL	$16.3 - $30.64 $8.17 Million - $15.4 Million	-501,002 Reduced 24.99%	1,503,451 $45.9 Million
Q2 2020 Aug 12, 2020	SELL	$7.95 - $18.81 $338,121 - $800,008	-42,531 Reduced 2.08%	2,004,453 $33.3 Million
Q1 2020 May 11, 2020	SELL	$6.45 - $14.04 $94,769 - $206,289	-14,693 Reduced 0.71%	2,046,984 $20.4 Million
Q4 2019 Feb 07, 2020	SELL	$12.97 - $15.94 $182,487 - $224,275	-14,070 Reduced 0.68%	2,061,677 $28.3 Million
Q3 2019 Nov 04, 2019	BUY	$14.75 - $20.87 $470,200 - $665,293	31,878 Added 1.56%	2,075,747 $31.5 Million
Q2 2019 Aug 05, 2019	SELL	$14.71 - $19.79 $71,181 - $95,763	-4,839 Reduced 0.24%	2,043,869 $40.2 Million
Q1 2019 May 01, 2019	BUY	$13.73 - $16.87 $196,572 - $241,527	14,317 Added 0.7%	2,048,708 $34 Million
Q4 2018 Feb 11, 2019	SELL	$10.6 - $17.49 $381,875 - $630,094	-36,026 Reduced 1.74%	2,034,391 $28.6 Million
Q3 2018 Nov 08, 2018	BUY	$16.65 - $21.85 $11.7 Million - $15.4 Million	703,282 Added 51.44%	2,070,417 $36.2 Million
Q2 2018 Aug 07, 2018	BUY	$14.8 - $18.8 $20.2 Million - $25.7 Million	1,367,135 New	1,367,135 $24.9 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$68.4 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.3 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$51.9 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.4 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$38.7 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account